Return to Listing

1 result(s) for

PI Name Protocol # Title
Zahi Mitri STUDY00020112 Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination with Ado-trastuzumab Emtansine (T-DM1) for Subjects with Unresectable Locally-advanced or Metastatic HER2+ Breast Cancer
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080